Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments.The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes, antisense, siRNAs, aptamers, DNAzymes, ribozymes, peptides, proteins); large-scale biology (genomics, functional genomics, proteomics, structural genomics, metabolomics, etc.); computational biology (algorithms and modeling), regenerative medicine (stem cells, tissue engineering, biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules), applied immunology (antibody engineering, xenotransplantation, T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below.
《自然生物技术》（Nature Biotechnology）是一份涵盖生物技术科学和商业的月刊。它发表与生物学、生物医学、农业和环境科学相关的技术/方法学的新概念，并涵盖这项研究的商业、政治、伦理、法律的和社会方面。第一个功能是由同行评审的研究部分完成的，第二个功能是由期刊前面的说明性工作完成的。我们为研究人员提供有关商业的新闻;我们为商业界提供有关研究发展的新闻。2我们正在积极寻求的核心领域的研究论文包括：核酸和蛋白质的分子工程;分子治疗（治疗基因、反义、siRNA、适体、DNA酶、核酶、肽、蛋白质）;大规模生物学（基因组学、功能基因组学、蛋白质组学、结构基因组学、代谢组学等）;计算生物学（算法和建模）、再生医学（干细胞、组织工程、生物材料）;成像技术;分析生物技术（分析物/大分子的传感器/检测器）、应用免疫学（抗体工程、异种移植、T细胞治疗）;粮食和农业生物技术;和环境生物技术。感兴趣领域的综合列表如下所示。
A comparison of single-cell trajectory inference methods
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0071-9
Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0217-9
Best practices for benchmarking germline small-variant calls in human genomes
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0054-x
An open resource for accurately benchmarking small variant and reference calls
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0074-6
Broad-spectrum resistance to bacterial blight in rice using genome editing
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0267-z
Accessing analytes in biofluids for peripheral biochemical monitoring
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0040-3
Toward a new generation of smart skins
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0079-1
SPECIFICATION OF POSITIONAL IDENTITY IN FOREBRAIN ORGANOIDS
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0085-3
TagGraph reveals vast protein modification landscapes from large tandem mass spectrometry data sets
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0067-5
The Kipoi repository accelerates community exchange and reuse of predictive models for genomics
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0140-0
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0178-z
Precision mouse models with expanded tropism for human pathogens
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0225-9
Engineered toxin–intein antimicrobials can selectively target and kill antibiotic-resistant bacteria in mixed populations
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0105-3
Worldwide CRISPR patent landscape shows strong geographical biases
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0138-7
Co-regulation map of the human proteome enables identification of protein functions
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0298-5
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0325-6
Supercooling extends preservation time of human livers
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0223-y
Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0070-x
Highly multiplexed single-cell RNA-seq by DNA oligonucleotide tagging of cellular proteins
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0372-z
Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy
来源期刊：Nature biotechnologyDOI：10.1038/s41587-019-0073-7
A systems biology pipeline identifies regulatory networks for stem cell engineering
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0159-2
Separating neuroethics from neurohype
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0230-z
Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up
来源期刊：Nature BiotechnologyDOI：10.1038/d41587-019-00023-6
Duchenne muscular dystrophy awaits gene therapy
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0103-5
Polarizing brain organoids
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0084-4
Sweet sensation
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0086-2
International regulatory changes poised to reshape access to marine genes
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0087-1
Public biotech 2018—the numbers
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0170-7
Rescuing imperfect antigens for immuno-oncology
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0248-2
Speed SPYing: adaptive clinical trials hit the gas
来源期刊：Nature BiotechnologyDOI：10.1038/d41587-019-00021-8
Reply to “Separating neuroethics from neurohype”
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0226-8
AI developers tout revolution, drugmakers talk evolution.
来源期刊：Nature biotechnologyDOI：10.1038/d41587-019-00033-4
Brain maps at the nanoscale
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0078-2
As the life science industry evolves, so do its talent needs
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0091-5
Second-quarter biotech job picture
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0213-0
Author Correction: Precision electronic medicine in the brain
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0319-4
Publisher Correction: Reply to ‘A lack of evidence for six times more anxiety and depression in US graduate students than in the general population’
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0211-2
One year, 1 lab, 16 spinouts
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0369-7
Publisher Correction: Radioactive drugs emerge from the shadows to storm the market
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0030-5
Monster investment puts Baltimore on biotech startup map
来源期刊：Nature BiotechnologyDOI：10.1038/d41587-019-00029-0
Evidence-based obviousness for use in patent prosecution and review
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0232-x
Show me the models
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0143-x
Publisher Correction: CRISPR target prediction remains blunt tool for clinical applications
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0107-1
Synthetic biology
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0177-0
First Rounders: Nina Tandon
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0243-7
First Rounders: Pardis Sabeti
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0270-4
Author Correction: Collaborative networks in gene editing
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0353-2
The ethics of neurotechnology
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0239-3
Brain–machine interfaces
来源期刊：Nature BiotechnologyDOI：10.1038/s41587-019-0251-7
Not-for-profit to launch antibiotic against drug-resistant tuberculosis.
来源期刊：Nature biotechnologyDOI：10.1038/d41587-019-00034-3
